DNA amplification in human gastric carcinomas

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Gastric carcinoma is a significant global health concern.
• Genomic alterations, including gene amplification, play a crucial role in cancer development.
• The BEK/K-sam gene, encoding growth factor receptors, is located in a frequently amplified region in gastric cancer cell lines.

Purpose of the Study:

• To investigate the frequency and significance of genomic amplification at chromosome 10q26 in primary gastric carcinomas.
• To determine if this amplification is specific to gastric cancer compared to other solid tumors.
• To assess the association of gene amplification with tumor characteristics and stage.

Main Methods:

• Analysis of genomic DNA from gastric carcinoma cell lines (KATO III, SNU-16) and primary gastric tumors.
• Utilized techniques to detect gene amplification within a specific 200 kb genomic region at 10q26.
• Examined amplification of additional genes (MYC, ERBB2, INT2) in primary gastric carcinomas.

Main Results:

• A 200 kb genomic segment containing the BEK/K-sam gene was amplified in 3.6% of primary gastric carcinomas.
• All amplified tumors were poorly differentiated.
• No amplification of this region was observed in other tested solid tumors.
• Including MYC, ERBB2, and INT2, the overall gene amplification frequency reached 19.4% in gastric carcinomas, associated with advanced stage.

Conclusions:

• The genomic region at 10q26, including the BEK/K-sam gene, is amplified in a subset of gastric carcinomas.
• This amplification appears specific to gastric cancer and is linked to aggressive tumor features.
• Gene amplification in solid tumors may be more common than previously recognized, highlighting potential therapeutic targets.